tilray set to report earnings this hour and ceo brendan kennedy will be here to talk about them noiningtangler. welcome back. >> thank you, sara good to be here. >> mike, another strong day for the markets led by cyclicals >> today it was quietly strong i would say. just kind of keeps churning higher you know, getting to the end of the first quarter, such a strong quarter. i think people feel underinvested when the market ticks higher yes, driven by cyclicals and point out that you had amazon, apple, microsoft all up more than 1% today and still is this kind of buy the familiar favorites just to get equity exposure because nothing else in the macro background changed and the market volatility seems benign at least for the moment and to me it's more low yields, you know, driving in a slow way people to kind of raise equity equity exposures and not keying off that incoming macro data. >> overall the pace now we have seen of the rebound since the lows, not quite as fast as the fall but nonetheless impressive. >> it is about as fast as it gets on the upside yes about more than 20% climb in

acquisitions recently including hemp food producer manitoba harvest in an interview with "closing bell" brendan kennedyaid that deal along with the passionage of the farm bill will help them enter the cbd market in the u.s. before the end of the year. >> the passage of the farm bill we achoired manitoba harvest, the largest hemp food company. when you think about retailers like albertson's and amazon and whole foods and costco looking to put cbd products on their shelves, they're going to go with the brand they know and the supply chain they trust like manitoba harvest which was part of the rationale behind that acquisition. we think we can use that in the u.s. to bring cbd products, hemp derived cbd products to market quickly. >> some other highlights on tilray's deal with anheuser-busch we can expect cannabis infused drinks to enter the canadian market by okay when asked why he sold the company's stock, he didn't seem to have a clear answer saying it was a small part of his portfolio. >> grasso. >> it's like trading biotech it's very binary so i own canopy and crotilray i laggard. the trader would ta